Amdocs (DOX) Tops Q3 EPS by 2c, Offers Q4 Guidance

Amdocs (NASDAQ: DOX) reported Q3 EPS of $1.07, $0.02 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.01 billion.

GUIDANCE:

Amdocs sees Q4 2020 EPS of $1.16-$1.22, versus the consensus of $1.16. Amdocs sees Q4 2020 revenue of $1.02-1.06 billion, versus the consensus of $1.03 billion.

For earnings history and earnings-related data on Amdocs (DOX) click here.

You May Also Be Interested In

• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance